TXNIP and hepatocellular carcinoma: Since CAST has tumor-promoting activity, we hypothesized that CAST upregulation in TXNIP-OE HCC-1954 cells (Supplementary Fig. 5A) might explain the late-onset acceleration in the growth of TXNIP-OE HCC-1954 tumors in NSG mice (Fig. 1F).